Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Capecitabine
Related studies linked through entity extraction aliases.
Efficacy and Safety Evaluation of Sintilimab or Placebo in Combination With XELOX as First Line Treatment in Patients With Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Bevacizumab Plus Capecitabin vs S-1 as Maintenance Treatment Following First-line Chemotherapy in the Patients With Advanced Colorectal Adenocarcinoma
- Status
- WITHDRAWN
- Phase
- PHASE3
Radiation-protection Effect of Amifostine in Locally Advanced Rectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Capecitabine in HER-2 Positive Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC
- Status
- UNKNOWN
- Phase
- PHASE2
Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
SHR-1210 in Combination With BP102 and XELOX in Patient With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
M6620 Plus Standard Treatment in Oesophageal and Other Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Recurrence Score-guiding Chemotherapy in Non-pCR HR Positive HER2 Negative Breast Cancer After Neoadjuvant Therapy
- Status
- UNKNOWN
- Phase
- PHASE2
Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Investigate Apatinib Combined Capecitabine on Adjuvant Therapy of Biliary Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
The Effect of Traditional Chinese Treatment Combined Adjuvant Chemotherapy in IIIb and IIIc Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Herzuma-capecitabine/Cisplatin for Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
QUILT-3.080: NANT Pancreatic Cancer Vaccine
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Chemotherapy Before & After Surgery in Patients With Resectable Gallbladder Cancer
- Status
- WITHDRAWN
- Phase
- PHASE3
SECOX as Neoadjuvant Therapy in Patients With Locally Advanced HCC
- Status
- COMPLETED
- Phase
- PHASE2